Cliquer ici pour nos articles archivés
2007 - May
- Good growth nationally in drug sales in 2006 E-sales to the U.S. decline
- Quebec extends free drug coverage to 300,000
- More hospitals asked to join patient safety campaign
- McGill-led team identifies spina bifida gene Groundbreaking research can make diagnosis easier
- Gene discovery raises hope of treatment for memory loss
- BIO 2007 - BOSTON, du 6 au 9 mai 2007
- Ontario budget puts $64 million into e-Health
- Multi-lingual kiosks tested in emergency rooms
- New partnership leverages promising Canadian stem cell IP MaRS and Canadian Stem Cell Network Partner in Translational Development Company Focused in the High Growth Area of Regenerative Medicine
- Sunnybrook’s surgical infections reduced by 40%
- BIOTECanada Responds to the Federal Government’s Budget Announcement
- Canadian scientists lead international autism genome discoveries
- New laws give Alberta pharmacists the power to prescribe certain medications
- Alberta doctors’ agreement would re-start POSP funding
- Calgary’s Sembiosys in GM insulin breakthrough
- Scientists warn of nanotech backlash
- Federal budget delivers on health care but still disappoints: CMAJ
- Health Canada approves Sprycel, a new treatment for chronic myeloid leukemia
- Canadian contribution to the US physician workforce
- Feds fund nurse mentoring program in British Columbia
- Ethanol makers dispute Parliamentary report on biofuels spending
- Ontario invests $114 million in new Brampton hospital
- Doctors’ ties to drug makers are put on close view
- A moving target: New ’smart’ drugs offer hope, but so far, benefits are limited and costs are high
- Translational research set to make “quantum leaps”: Bringing cancer science to the bedside
- US national survey reveals direct-to-consumer advertising is achieving return on investment
- Pfizer’s patent on Norvasc nullified Canadian generic drug manufacturer Apotex, Inc. expected to launch generic product: Vows to end to anti-competitive patents settlements to provide consumer’s access to generic medicines
- Lipitor provides unprecedented cardiovascular risk reductions in diabetes patients with metabolic syndrome and in stroke patients
- Politics called threat to CDC Ex-directors say integrity, morale at risk
- Study Suggests New Avenue On Diabetes
- MedImmune ready for purchase bid by major drugmakers
- British competition watchdog begins drug supply probe, after controversial Pfizer deal
- Drug counterfeiters would face jail under new EU rules
- Multi-talented RFID tag hits pharma market
- Wyeth: Childhood immunization against pneumonia cuts hospital admissions by almost 40%
- Pfizer drug distribution deal triggers market investigation
- US pharma outlook stable in 2007 - Moody’s
- AIDS drugs sales seen topping $10 billion by 2015
- Health experts support access to vaccines for developing nations
- Thailand threatens to expand generic drugs for cancer, AIDS
- Indonesia shares bird flu virus samples
- AstraZeneca inaugurates state-of-the-art global process R&D lab in Bangalore
- Japan doctors warned not to give Tamiflu to teenagers
- Ten ways to keep your PC secure at Wi-Fi hotspots
2007 - April
- Abbott Canada Launches Oscient Pharmaceuticals’ FACTIVE Tablets in Canada Fluoroquinolone antibiotic now available for the treatment of AECB
- Atrium Continues its Growth with 86% Increase in Net Earnings for Fiscal 2006 (All amounts are in U.S. dollars.)
- Montreal Hospitals Score Low on Accessibility, Survey Says
- Aegera Therapeutics Appoints New Chairman and Director
- From a Distance There is Surgery – Thanks to Telehaptics Doctors to Reach Out to Patients Thousands of Miles Away
- New Guidance for Oncology Submissions
- Federal Government Announces More Funding for Biofuel Initiatives
- Capital Health Launches Project to Improve Access
- Saskatchewan Researcher Turns Waste Straw Into Construction-Quality Material
- Some US Employers Are Offering Free Drugs
- Thailand Plans to Break Patents on 14 Drugs: Firms
- Angered U.S. Firm Excludes Thailand from New Drugs
- Doctors Without Borders MSF Denounces Abbott’s Move to Withhold Medicines From People in Thailand
- AstraZeneca to Cut 850 More Jobs in Sweden
- International Narcotics Control Board (INCB) Warns of Counterfeit Medicines Flowing into Many Countries
- FDA Chief Suggests `Junior’ Status for Copies of Biotech Drugs
- Lipitor Significantly Reduced the Risk of Serious Cardiovascular Events Compared With Simvastatin in an 80,000-Patient Analysis of a Real-World Managed Care Database
- Bayer HealthCare Announces Concrete Plans for the Global Synergy Goals and Job Cuts
- New Approach to Asthma Treatment Approved by Health Canada
- Ten-year Trend: Surgeries Up, Hospitalizations Down
- Strives to Keep You Competitive in Changing Health Care Market
- VIHA signs $11 Million Agreement with GE
- British Columbia Announces New Surgical Registry
- 2006 a Record Year for Bayer
- You’re a genius and you don’t even know it
- Ivey Strives to Keep You Competitive in Changing Health Care Market
2007 - March
- Emergis signs contract to deploy EHR across Montreal
- Quebec plans to allow prescription drug prices to rise for the first time since 1994.
- Pilot to study use of GPS in diabetes care
- SSHA riddled with problems, operational review finds
- Three Ontario cities among 21 ’smartest’ global communities
- Federal Government announces $2.6m project for pediatric wait times
- Edmonton plans $60 million orthopedic surgery centre
- Calgary Scientific’s 3D medical imaging system integrated into EMR
- Inflazyme Pharmaceuticals Announces Corporate Restructuring
- Hospitals unprepared for pandemic surge
- Health-care orgs explore scheduling app for pandemic preparation SARS provided lessons on communications issues, OHA attendees told
- Billion dollar pills: An overhaul at Pfizer, the biggest and most conservative of drugs firms, shows what ails the industry
- Doctors and Drug Makers: A Move to End Cozy Ties
- Provinces unite on cancer drug evaluations
- J&J film takes drug ads into new territory
2007 - February
- Ecopia Announces Agreement with Caprion to Combine their Businesses and Launch a $30 Million Private Placement Aim is to create a leading oncology and infectious disease firm
- Montreal Economy and Job Market Deemed “Hyperactive”
- TBI Appoints New Executive Director
- McMaster Awarded $1m from Gates Foundation for HIV Research
- One of Canada’s Top 10 Life Science Companies Closes Ottawa’s Largest Life Science VC Deal of 2006
- Federal Government to Invest up to $25 Million in Saskatoon Vaccine Laboratory
- Federal funding gives the bio-economy a boost
- CMAJ embraces new Editor-in-Chief (Editorial comment)
- Ontario Commission Blames Poor Hospital Infection-Control for 2003 SARS Epidemic in Toronto
- Pfizer Reduces Global Sales Force; 285 Layoffs Announced for Canada
- Prepare for Wi-Fi Invasion, Face Recognition, and On-line Application Surgence Wi-Fi
2006 - February/March
2006 - January
- Biotechnology Industry Ends 2005 with Breakthrough Product Approvals and Steady Financing
- Press Release: New Scientific Advisor at CCPE
- CCPE is pleased to announce that it is currently developing a new course on Metabolic Syndrome and diabetes
- CCPE HIGHLIGHTS 2005: The CCPE has identified 17 initiatives that had an impact on our membership in 2005.
- For fifth consecutive year, GlaxoSmithKline recognized as one of the 50 Best Employers in Canada
- Pharmaceutical Advertising Regulatory Agency launches Spring 2006 Industry Education Program
- Press Release: Attention Business/Financial Editors: Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer
2005 - December
2005 - November
- Ten Benefits of PMCQ Membership
- QSV Biologics, Ltd. and Helix Biopharma Corporation Sign Letter of Intent to enter into an Agreement for Process Development and Clinical Manufacture of L-DOS47 Lung Cancer Therapeutic
- QSV Biologics, Ltd. and BioAxone Therapeutic, Inc. Sign Letter of Intent to enter into an Agreement for Clinical Manufacture of BA-210 Therapeutic
- Helping Biotech Companies Help New Grads: Wage Subsidy Program Gives Young People a Foot in the Door of the Biotech Industry
2005 - August/September
2005 - July
- NEWS RELEASE: May 31, 2005 CCPE is pleased to announce that it is currently developing a new course on Evidence-based Medicine.
- NEWS RELEASE: MDS PHARMA SERVICES SPONSORS THE BIOMARKER ALLIANCE™
- NEWS RELEASE: May 21, 2005 State of Punjab to collaborate with the Province of Saskatchewan
- FOR IMMEDIATE RELEASE: Hill & Knowlton’s Life Sciences Director Recognized with Biotech Industry Award
- 41 Quebec Companies and Organizations to Participate in the Biggest Biotechnology Trade Show in the World - BIO 2005
- Ag-West Bio: Investing in start-up life-science companies
- AN IMPORTANT MESSAGE FROM THE PRESIDENT OF BIOQUEBEC
- Caprion Pharmaceuticals Announces Biomarker Research Collaboration With Boehringer Ingelheim
- Wyeth Expands Caprion Biomarker Collaborations to Include Two Clinical Biomarker Programs
- Press Release: Creation of the FONDS-Soutien Laval THE GOVERNMENT ANNOUNCES $3 MILLION FOR LAVAL COMPANIES
- News Release: Pharmahorizons Inc. and Innovus Research Inc. Join Forces
2005 - Spring
- NEWS RELEASE: FOR IMMEDIATE RELEASE Asacol® 800 Tablets Approved in Canada for the Treatment of Moderately Active Ulcerative Colitis
- Executive Director Golden Horseshoe Biosciences Network
- FOR IMMEDIATE RELEASE: PALADIN AND WATSON ENTER INTO MARKETING AND SUPPLY AGREEMENT FOR TRELSTAR® IN CANADA
- OLSC Event Calendar 2005
- President’s Message: Report and Annual Review
- NEWS RELEASE: Angiotech partner announces first international trial of a paclitaxel-eluting stent for peripheral artery disease * New treatment could benefit millions who suffer from seriously under-diagnosed disease
2005 - February
- NEWS RELEASE: Pharmaceutical Advertising Regulatory Agency Announces June 2005 Industry Education Series
- Speech - Innovation brings better healthcare to Canadians André Marcheterre, President Merck Frosst Canadian Club of Ottawa - February 15, 2005
- NEWS RELEASE: According to a BIOQuebec Survey - Quebec Universities Must Become More Effective in Commercializing Their Technology Innovations
- KGK SYNERGIZE PURCHASES LC/MS/MS, EXPANDING SERVICES OFFERED TO THEIR CLIENTELE
- Ottawa Life Science Council Events Listings (Spring 2005)
- BioProducts Showcase and Reception March 10, 2005 (200 West Block)
- MAJOR IMPROVEMENTS - AMÉLIORATIONS MAJEURES REGISTRATION PERIOD – February 2005 – EXAMS June to November 2005
- DISTRIBUTION OF SEATS ON CCPE BOARD OF DIRECTORS
- FDA Fact Sheet: February 15, 2005 FDA Press Office FDA Improvements in Drug Safety Monitoring
2005 - January
- NEWS RELEASE: Thursday, January 6th, 2005 Proposals to establish a worldwide register of clinical trials on new prescription-only medicines are being fully endorsed by the UK-based pharmaceutical industry, the Association of the British Pharmaceutical Industry (ABPI) announced today.
- NEWS RELEASE: Global Industry Position On Disclosure of Information About Clinical Trials IFPMA
- CCPE 2002-2003 Gold Medal Recipients Recognized at RX&D AGM
- Ag-West Bio welcomes new staff and members to the Board of Director
- Effective April 1, 2005: PAAB ADVISORY: IMPORTANT PAAB CODE REVISION On December 3, 2004 the PAAB Members approved revisions to the PAAB Code. Please note that this version of the Code will not come into effect until April 1, 2005.
- NEWS RELEASE: Pharmaceutical Launch: New Study Reveals Brand Spending Patterns
- Pharmaceutical Advertising Regulatory Agency Launches 2005 Industry Education Program
- Peter Brenders, recently of Genzyme Canada, is the new President of BIOTECanada